| Full Name | Kyle Melfe |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 1250 Waters Pl, Bronx, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700449873 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 023449 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kyle Melfe, PA 109 Forest Rd, Wallkill, NY 12589-2918 Ph: (845) 527-6851 | Kyle Melfe, PA 1250 Waters Pl, Bronx, NY 10461-2720 Ph: (347) 577-4460 |
News Archive
CHARGE, which affects 1 in 10,000 babies, is an acronym whose letters stand for some of the more common symptoms of the condition: coloboma of the eye, heart defects, atresia of the choanae, retardation of growth and/or development, genital and/or urinary abnormalities, and ear abnormalities and deafness.
A study published in the online journal Hepatology reports a potential new NADPH oxidase (NOX) inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease that can lead to loss of liver function.
Babies whose mothers who receive influenza vaccines while pregnant appear less likely to be infected with flu or hospitalized for respiratory illnesses in their first six months of life, according to a report posted online today that will appear in the February 2011 print issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
AmpliPhi Biosciences Corporation, a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, presented data at the European Congress of Clinical Microbiology and Infectious Diseases summarizing both the in vitro and in vivo activity of its proprietary, investigational phage mix AB-PA01.
AtheroNova Inc., a biotech company focused on the research and development of compounds to regress atherosclerotic plaque has established a clear development plan, including Phase I and Phase II protocol outlines, based on the recently finalized minutes of its pre-IND meeting with the U.S. Food and Drug Administration (FDA) for its AHRO-001, a compound for the treatment of atherosclerosis.
› Verified 6 days ago
Jeffrey Bruce Knox, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 199 Mount Eden Pkwy Fl 4, Bronx, NY 10457 Phone: 718-590-1800 | |
Paul Kleinman, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2016 Bronxdale Ave, Bronx, NY 10462 Phone: 718-863-8695 Fax: 718-863-5147 | |
Dr. Eial Faierman, MD Orthopedic Surgery Medicare: May Accept Medicare Assignments Practice Location: 3612 East Tremont Avenue, Bronx, NY 10465 Phone: 718-409-9494 Fax: 718-824-8026 | |
Dr. Vanessa Charubhumi, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-4321 | |
Dr. David M.s. Shein, M.D. Orthopedic Surgery Medicare: May Accept Medicare Assignments Practice Location: 1250 Waters Pl, Suite 903, Bronx, NY 10461 Phone: 718-450-9955 Fax: 718-450-9988 | |
Dr. Shai Shemesh, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2600 Netherland Ave, Apt 925, Bronx, NY 10463 Phone: 646-647-5973 | |
Paul E Levin, MD Orthopedic Surgery Medicare: May Accept Medicare Assignments Practice Location: Mmc - Dept. Of Orthopedic Surg, 3400 Bainbridge Avenue, 6th Fl, Bronx, NY 10467 Phone: 718-920-2060 |